Treatment cost assessment for COVID-19 inpatients in Shenzhen, China 2020-2021: facts and suggestions.

Yuan, Shasha; Li, Ting; Chu, Cordia; Wang, Xiaowan; Liu, Lei

Yuan, Shasha; Li, Ting; Chu, Cordia; Wang, Xiaowan; Liu, Lei.

Afiliación

Yuan S; Institute of Medical Information & Library, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Li T; National Clinical Research Centre for Infectious Diseases, The Third People's Hospital of Shenzhen, Shenzhen, China.
Chu C; Centre for Environment and Population Health, School of Medicine and Dentistry, Griffith University, Brisbane, QLD, Australia.
Wang X; Centre for Environment and Population Health, School of Medicine and Dentistry, Griffith University, Brisbane, QLD, Australia.
Liu L; Institute of Medical Information & Library, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

Front Public Health ; 11: 1066694, 2023.

Article en En | MEDLINE | ID: mdl-37213645

Asunto(s)

COVID-19; Humanos; COVID-19/epidemiología; COVID-19/terapia; Pacientes Internos; Estudios Transversales; Tratamiento Farmacológico de COVID-19; Costos de la Atención en Salud; Costo de Enfermedad

Palabras clave

COVID-19; China; clinical classification; cost components; inpatient treatment cost

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Guideline / Health_economic_evaluation / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Front Public Health Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google